Loading clinical trials...
Loading clinical trials...
Parkinson's disease (PD) is the second most common neurodegenerative disease, characterized pathologically by the progressive loss of dopaminergic neurons in the substantia nigra and clinically by the...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Kahramanmaras Sutcu Imam University
NCT07467460 · PARKINSON DISEASE (Disorder), Alzheimer s Disease, and more
NCT07422675 · PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease
NCT07360977 · PARKINSON DISEASE (Disorder), Multiple Sclerosis (MS) - Relapsing-remitting, and more
NCT07351032 · PARKINSON DISEASE (Disorder)
NCT07306104 · PARKINSON DISEASE (Disorder)
Kahramanmaraş Sütçü imam University
Kahramanmaraş, Onikişubat
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions